Semaglutide reduces HbA1c across baseline HbA1c subgroups across Sustain 1-5 Clinical Trials. Semaglutide, a GLP-1 analog for once-weekly subcutaneous treatment of T2D, demonstrated superior reductions in HbA1c and body weight across sustained 1-5 clinical trials.
About Us
Our goal is to provide a healthy, vital and energetic body. Our commitment is your well-being. Your care and health is our priority, feeling good and having a body in harmony will make a difference in your life.
Contact info
Hours of Operation
- Mon - Fri: 10:00 AM - 5:00 PM
- Sat: Closed
- Sun: Closed
Copyright © 2023 Lotus Wellness Institute, All Rights Reserved.
